Guangdong Procapzoom Biosciences Co., Ltd.

This early-phase study tests the safety and tolerability of a new drug called SZ1003 in 12 people with advanced liver cancer that has not responded to at least two prior treatments. The main goal is to check for side effects over 24 weeks, while also looking at whether the drug c…

This early-stage trial tests a new treatment using donor immune cells (CAR-NK cells) that are designed to target and calm the overactive immune system in people with severe myasthenia gravis. The study will enroll 15 adults aged 18-65 whose condition has not responded to standard…

This early study tests whether special contact lenses (MSCohi-O) can help with dry eyes caused by Sjögren's syndrome. Twelve adults who haven't improved with standard treatments will wear the lenses and be monitored for safety and symptom changes over 29 days. The goal is to see …

This early-phase trial tests whether exosomes (tiny particles from cells) can safely ease dry eye symptoms in people with Sjögren's syndrome. About 12 adults whose dry eye hasn't improved with standard treatments will receive multiple doses. Researchers will monitor side effects …